Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MVAC vs Carboplatin and Paclitaxel in Advanced Urothelial Carcinoma
NCT00003376Phase 3Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Dec 1998
- Primary completion
- Sep 2005
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised trial of methotrexate, vinblastine, doxorubicin, cisplatin, carboplatin and 1 more in urothelial carcinoma (UC) (2 arms), sponsored by Eastern Cooperative Oncology Group. Primary endpoints: Objective Response Rate, Duration of Remission and 2 more. Started Dec 1998; status: completed.
02
Drugs
methotrexatevinblastinedoxorubicincisplatincarboplatin
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT00003376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003376.